올릭스

226950KOSDAQSector: Pharma & Biotech

₩109,200▼ 4.88%Market cap ₩2.29TAs of Jul 21, 2026 close · updated once daily

Grade C48.4 ptsTop 57% of 2,523 stocksPreviously B

Financial strength

52.9

Growth momentum

65.4

Price attractiveness

31.1

As of Jul 21, 2026 close · This grade is not a buy/sell recommendation — it is information mechanically scored from public data using a fixed formula.

Financial strength

52.9

How much debt does it carry relative to equity?

Debt-to-equity ratio

30.2%

✓ Above median · Top 29.5% in sector

Sector median 51.5%

Can it cover what's due within a year?

Current ratio

660.5%

✓ Above median · Top 20.5% in sector

Sector median 191.3%

How much of revenue becomes profit?

Operating margin

-204.4%

✗ Below median · Top 81.3% in sector

Sector median -2.3%

How much did it earn on its own capital?

ROE (return on equity)

-10.5%

✗ Below median · Top 57.1% in sector

Sector median -4.5%

Source filing: annual report (consolidated) — view original ↗

Growth momentum

65.4

How much did revenue grow in a year?

Revenue growth (YoY)

158.3%

✓ Above median · Top 5.7% in sector

Sector median 6.4%

Has it grown steadily over three years?

Revenue 3-year CAGR

16.3%

✓ Above median · Top 17.3% in sector

Sector median 4.9%

Did core profits grow in a year?

Operating income change (YoY)

3.1%

✗ Below median · Top 51.6% in sector

Sector median 3.6%

Are core profits higher than three years ago?

Operating income change (3Y)

-34.0%

✗ Below median · Top 63.7% in sector

Sector median 3.5%

Source filing: annual report (consolidated) — view original ↗

Price attractiveness

31.1

Is the price expensive relative to earnings?

P/E (price-to-earnings)

Loss-making (P/E not computable)

✓ Above median · Top 47.4% in sector

Sector median P/E of profitable peers 14.4x · 57% loss-making

Is the price expensive relative to book value?

P/B (price-to-book)

15.34x

✗ Below median · Top 90.4% in sector

Sector median 1.39x

Valuation uses the Jul 21, 2026 close and market cap

Grade distribution of 248 stocks in Pharma & Biotech

S1A52B66C51D61F15